Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amifostine reduces inflammation and protects against 5-fluorouracil-induced oral mucositis and hyposalivation.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2019
Same author

Correlation between RR, inter-systolic and inter-diastolic intervals and their differences for the analysis of spontaneous heart rate variability.

Physiological measurement·2016
Same author

Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis.

Scandinavian journal of rheumatology·2012
Same author

Effect of topical clay application on the synthesis of collagen in skin: an experimental study.

Clinical and experimental dermatology·2012
Same author

Chronic polyarthritis as the first manifestation of juvenile systemic lupus erythematosus patients.

Lupus·2011
Same author

Acute pancreatitis in juvenile systemic lupus erythematosus: a manifestation of macrophage activation syndrome?

Lupus·2010

Related Experiment Video

Updated: May 26, 2026

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
08:16

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

Interleukin-18 in chronic joint diseases.

A P N Lotito1, C A A Silva, S B V Mello

  • 1Department of Paediatrics, University of Sao Paulo, Brazil. paolalotito@ig.com.br

Autoimmunity Reviews
|February 24, 2007
PubMed
Summary

Interleukin-18 (IL-18) plays a key role in inflammatory joint diseases like rheumatoid arthritis. This study summarizes research on IL-18

Area of Science:

  • Immunology
  • Rheumatology
  • Cytokine Biology

Background:

  • Interleukin-18 (IL-18) is a pro-inflammatory cytokine within the IL-1 superfamily.
  • IL-18 exhibits potent Th1-promoting activities, often in conjunction with IL-12.

Purpose of the Study:

  • To investigate the role of IL-18 in inflammatory joint diseases.
  • To summarize in vivo and in vitro studies on IL-18's impact on the arthritic process.
  • To elucidate IL-18's function within the network of inflammatory mediators.

Main Methods:

  • Review and synthesis of existing in vivo and in vitro studies.
  • Analysis of IL-18's pro-inflammatory actions in arthritis models.
  • Examination of IL-18's interactions within the cytokine network.

More Related Videos

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
09:00

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment

Published on: June 24, 2020

In Vivo Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints
10:10

In Vivo Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints

Published on: December 9, 2025

Related Experiment Videos

Last Updated: May 26, 2026

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
08:16

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
09:00

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment

Published on: June 24, 2020

In Vivo Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints
10:10

In Vivo Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints

Published on: December 9, 2025

Main Results:

  • IL-18 is implicated in the pathogenesis of rheumatoid arthritis, adult onset Still's disease, and juvenile idiopathic arthritis.
  • Evidence highlights IL-18's contribution to the inflammatory cascade in arthritic conditions.
  • IL-18 participates in a complex interplay with other mediators driving joint inflammation.

Conclusions:

  • Interleukin-18 is a significant factor in the development and progression of inflammatory joint diseases.
  • Targeting IL-18 may offer therapeutic potential for conditions like rheumatoid arthritis.
  • Further research into IL-18's network interactions is warranted for comprehensive understanding.